CAUSALITY BETWEEN R&D EXPENSES AND PROFITABILITY & GROWTH: AN EXAMINATION ON BIST

Öz

In this study, two-way relationships between R&D expenses of enterprises and their business performance in terms of profitability and growth and reciprocal effects are examined. For this purpose, accounting-based panel data of firms quoted on Borsa Istanbul and having incessantly R&D expenses between 2005-2019 are used. Dumitrescu and Hurlin Heterogeneous Causality Test is performed for panel vector autoregressive (PVAR) models.
According to the results of the study, Granger causality from R&D Intensity to assets growth is detected, and close to the expectations, the positive relationship usually stands out in the firm-based analysis. Moreover, Granger causality from R&D Intensity to return on assets is identified, but contrary to the expectations, the relationship is predominantly negative according to firm-based examination. In addition, Granger causality from R&D Intensity to return on equity, to return on sales and to equity growth are ascertained. On the other hand, Granger causality from equity growth and return on sales to R&D Intensity are identified.

Anahtar Kelimeler

• R&D Expenses
• Profitability
• Growth
• PVAR Model
• Heterogeneous Causality Test

AR-GE GİDERLERİ İLE KÂRLILIK VE BÜYÜME ARASINDA NEDENSELLİK İLİŞKİSİ: BIST ÜZERİNE BİR İNCELEME

Öz

Bu çalışmada işletmelerin Ar-Ge giderleri ile kârlılık ve büyüme performansları arasındaki iki yönlü ilişkiler ve karşılıklı etkiler incelenmiştir. Bu amaçla, hisse senetleri Borsa İstanbul’da işlem gören, 2005-2019 yılları arasında aralıksız Ar-Ge giderleri bulunan işletmelerin muhasebe temelli panel verileri kullanılmıştır. Panel vektör otoregresif (PVAR) modeller ile Dumitrescu ve Hurlin Heterojen Nedensellik Testi gerçekleştirilmiştir. Çalışma sonucunda, Ar-Ge yoğunluğundan aktiflerde büyümeye doğru bir Granger nedensellik ilişkisi bulunduğu ve işletme bazlı incelemede beklentiye yakın şekilde çoğunlukla pozitif ilişkinin öne çıktığı görülmüştür. Buna ilaveten, Ar-Ge yoğunluğundan aktif kârlılık oranına doğru Granger nedensellik ilişkisi bulunduğu, ancak işletme bazlı incelemeye göre beklentinin aksine ağırlıklı olarak negatif ilişkinin öne çıktığı tespit edilmiştir. Ayrıca Ar-Ge yoğunluğundan özsermaye kârlılık oranına doğru, satışların kârlılık oranına doğru ve özsermayede büyümeye doğru Granger nedensellik ilişkisi bulunmuştur. Diğer yandan, özsermayede büyümeden ve satışların kârlılık oranından Ar-Ge yoğunluğuna doğru Granger nedensellik ilişkisinin bulunduğu tespit edilmiştir.

Anahtar Kelimeler

• Ar-Ge Giderleri
• Kârlılık
• Büyüme
• PVAR Modeli
• Heterojen Nedensellik Testi

Kaynakça

1. Aggelopoulos, E., Eriotis, N., Georgopoulos, A. ve Tsamis, A. (2016). R&D activity and operating performance of small and medium-sized enterprises (SMEs): The case of a small open economy. Journal of Accounting and Taxation, 8(4), 40–50. doi:10.5897/jat2016.0233
2. Alper, D. ve Aydoğan, E. (2016). Relationships between R&D and corporate performance: An empirical analysis in Istanbul Stock Exchange. Paradoks Ekonomi, Sosyoloji ve Politika Dergisi, 11(2), 96–114.
3. Anagnostopoulou, S. C. ve Levis, M. (2008). R&D and performance persistence: Evidence from the United Kingdom. International Journal of Accounting, 43(3), 293–320. doi:10.1016/j.intacc.2008.06.004
4. Ayaydın, H. ve Karaaslan, İ. (2014). The effect of research and development investment and desorptive capacity on firm performance. Bilgi Ekonomisi ve Yönetimi Dergisi, IX(II), 43–59.
5. Baltacı, N., Ayaydın, H. ve Karakaya, A. (2017). Research, development, and firm growth: Evidence from Turkey. IV. International Balkan and Near Eastern Social Sciences Congress Series içinde (ss. 287–297).
6. Bogliacino, F. ve Pianta, M. (2013). Profits, R&D, and innovation-a model and a test. Industrial and Corporate Change, 22(3), 649–678. doi:10.1093/icc/dts028
7. Borsa İstanbul. (2020). Mali Tablolar Arşiv (2009 ve öncesi). https://www.borsaistanbul.com/tr/sayfa/476/mali-tablolar-arsiv-2009-ve-oncesi adresinden erişildi.
8. Branch, B. (1974). Research and development activity and profitability: A distributed lag analysis. Journal of Political Economy, 82(5), 999–1011.

9. Chen, T. chun, Guo, D. Q., Chen, H. M. ve Wei, T. ti. (2019). Effects of R&D intensity on firm performance in Taiwan’s semiconductor industry. Economic Research-Ekonomska Istraživanja, 32(1), 2377–2392. doi:10.1080/1331677X.2019.1642776
10. Coad, A. ve Grassano, N. (2018). Firm growth and R & D investment: SVAR evidence from the world’s top R&D investors. Industry and Innovation, 26(5), 508–533. doi:10.1080/13662716.2018.1459295
11. Coad, A. ve Rao, R. (2010). Firm growth and R&D expenditure. Economics of Innovation and New Technology, 19(2), 127–145. doi:10.1080/10438590802472531
12. Coad, A., Segarra, A. ve Teruel, M. (2016). Innovation and firm growth: Does firm age play a role? Research Policy, 45(2), 387–400. doi:10.1016/j.respol.2015.10.015
13. Del Monte, A. ve Papagni, E. (2003). R&D and the growth of firms: Empirical analysis of a panel of Italian firms. Research Policy, 32(6), 1003–1014. doi:10.1016/S0048-7333(02)00107-5
14. Demirel, P. ve Mazzucato, M. (2012). Innovation and firm growth: Is R&D worth it? Industry and Innovation, 19(1), 45–62. doi:10.1080/13662716.2012.649057
15. Demirgüneş, K. ve Üçler, G. (2016). Ar-Ge yatırımları ve büyüme: İmalat sektörü üzerine ampirik bir çalışma. İstanbul Üniversitesi İşletme Fakültesi Dergisi, 45(1), 53–64.
16. Deschryvere, M. (2014). R&D, firm growth and the role of innovation persistence: An analysis of Finnish SMEs and large firms. Small Business Economics, 43(4), 767–785. doi:10.1007/s11187-014-9559-3
17. Dumitrescu, E. I. ve Hurlin, C. (2012). Testing for Granger non-causality in heterogeneous panels. Economic Modelling, 29(4), 1450–1460. doi:10.1016/j.econmod.2012.02.014
18. Eberhardt, M. (2011). xtmg -- Estimating panel time series models with heterogeneous slopes. Boston College. https://fmwww.bc.edu/RePEc/bocode/x/xtmg.html adresinden erişildi.
19. Elmas, B. ve Polat, M. (2016). BIST kurumsal yönetim endeksine kayıtlı imalat firmaları özelinde Ar-Ge yatırımlarının firma performanına etkisinin araştırılması. Pressacademia Procedia, Global Business Research Congress (GBRC - 2016) içinde (C. 2, ss. 648–663). doi:10.17261/pressacademia.2016118687
20. Falk, M. (2012). Quantile estimates of the impact of R&D intensity on firm performance. Small Business Economics, 39(1), 19–37. doi:10.1007/s11187-010-9290-7
21. García-Manjón, J. V. ve Romero-Merino, M. E. (2012). Research, development, and firm growth. Empirical evidence from European top R&D spending firms. Research Policy, 41(6), 1084–1092. doi:10.1016/j.respol.2012.03.017
22. Grabowski, H. ve Vernon, J. (2000). The determinants of pharmaceutical research and development investments. Journal of Evolutionary Economics, (10), 201–215. doi:10.1515/1538-0645.1511
23. Güriş, B. (2015). Panel Vektör Otoregresif Modeller ve Panel Nedensellik. S. Güriş (Ed.), Stata ile Panel Veri Modelleri içinde (1. bs., ss. 291–304). İstanbul: Der Yayınları.
24. Güzen, H. D. ve Başar, B. (2019). Ar-Ge harcamalarının raporlanması ve kârlılığa etki̇si̇: BİST sınai̇ endeksi işletmeleri̇ üzerine bir araştırma. Anadolu Üniversitesi İktisadi ve İdari Bilimler Fakültesi Dergisi, 20(2), 1–24.
25. Han, I. ve Chuang, C.-M. (2011). The impacts of R&D investment on company performance: US vs. Taiwanese technology-intensive industry. Review of Pacific Basin Financial Markets and Policies, 14(1), 171–194. doi:10.1142/S0219091511002184
26. Işık, N., Engeloğlu, Ö. ve Kılınç, E. C. (2016). Araştırma ve geliştirme harcamalarının, kârlılık ve satışlar üzerindeki etkisi: Borsa İstanbul firmaları üzerine bir uygulama. Erciyes Üniversitesi İktisadi ve İdari Bilimler Fakültesi Dergisi, (47), 27–46.
27. Jaisinghani, D. (2016). Impact of R&D on profitability in the pharma sector: an empirical study from India. Journal of Asia Business Studies, 10(2), 194–210. doi:10.1108/JABS-03-2015-0031
28. Kamuyu Aydınlatma Platformu. (2020). Finansal Tablolar. www.kap.org.tr adresinden erişildi.
29. Lee, M. ve Choi, M. (2015). Analysis on time-lag effect of research and development investment in the pharmaceutical industry in Korea. Osong Public Health and Research Perspectives, 6(4), 241–248. doi:10.1016/j.phrp.2015.07.001
30. Lee, M. H. ve Hwang, I. J. (2003). Determinants of corporate R&D investment: An empirical study comparing Korea’s IT industry with its non-IT industry. ETRI Journal, 25(4), 258–265. doi:10.4218/etrij.03.0101.0401
31. Lin, Z., Ge, C. ve Goh, K. Y. (2011). R&D investment and firm performance in IT companies: An empirical investigation across IT industry sectors. PACIS 2011 - 15th Pacific Asia Conference on Information Systems: Quality Research in Pacific içinde (ss. 1–15).
32. Lopez, L. ve Weber, S. (2017). Testing for Granger causality in panel data. The Stata Journal, 17(4), 972–984. Morbey, G. K. (1988). R&D: Its relationship to company performance. Journal of Product Innovation Management, (5), 191–200.
33. Morbey, G. K. ve Reithner, R. M. (1990). How R&D affects sales growth, productivity and profitability. Research-Technology Management, 33(3), 11–14. doi:10.1080/08956308.1990.11670656
34. Nunes, P. M., Serrasqueiro, Z. ve Leitão, J. (2012). Is there a linear relationship between R&D intensity and growth? Empirical evidence of non-high-tech vs. high-tech SMEs. Research Policy, 41(1), 36–53. doi:10.1016/j.respol.2011.08.011
35. OECD. (2015). Frascati Manual 2015: Guidelines for Collecting and Reporting Data on Research and Experimental Development (7. bs.). Paris: OECD Publishing. doi:http://dx.doi.org/10.1787/9789264239012-en
36. OECD. (2020). Main Science and Technology Indicators (MSTI) database. 15 Eylül 2020 tarihinde https://stats.oecd.org/Index.aspx?DataSetCode=MSTI_PUB adresinden erişildi.
37. Oliveira, B. ve Fortunato, A. (2017). Firm growth and R&D: Evidence from the Portuguese manufacturing industry. Journal of Evolutionary Economics, 27(3), 613–627. doi:10.1007/s00191-016-0487-z
38. Othman, R. ve Ameer, R. (2009). Determinants and persistence of research and development investments: Evidence from Malaysia. International Journal of Emerging Markets, 4(3), 275–292. doi:10.1108/17468800910968427
39. Pantagakis, E., Terzakis, D. ve Arvanitis, S. (2012). R&D investments and firm performance: An empirical investigation of the high technology sector (software and hardware) in the E.U. SSRN Electronic Journal. doi:10.2139/ssrn.2178919
40. Seçilmiş, N. (2012). Yeni ekonomi çerçevesinde yapılan Ar-Ge faaliyetlerinin büyümeye katkısı: Gaziantep örneği. Gaziantep Üniversitesi. Yayımlanmamış Doktora Tezi.
41. Simanjuntak, D. G. ve Tjandrawinata, R. R. (2011). Impact of profitability, R&D intensity, and cash flow on R&D expenditure in pharmaceutical companies. SSRN Electronic Journal, (April 2011). doi:10.2139/ssrn.1824267
42. Sougiannis, T. (1994). The accounting based valuation of corporate R&D. The Accounting Review, 69(1), 44–68.
43. Tatoğlu, F. Y. (2013). İleri Panel Veri Analizi: Stata Uygulamalı (2. bs.). İstanbul: Beta Yayıncılık.
44. Tatoğlu, F. Y. (2017). Panel Zaman Serileri Analizi: Stata Uygulamalı (1. bs.). İstanbul: Beta Yayıncılık.
45. UNESCO. (2020). Global Investments in R&D. http://uis.unesco.org/sites/default/files/documents/fs59-global-investments-rd-2020-en.pdf adresinden erişildi.
46. Vithessonthi, C. ve Racela, O. C. (2016). Short- and long-run effects of internationalization and R&D intensity on firm performance. Journal of Multinational Financial Management, (34), 28–45. doi:10.1016/j.mulfin.2015.12.001
47. Wang, C. H. (2011). Clarifying the effects of R&D on performance: Evidence from the high technology industries. Asia Pacific Management Review, 16(1), 51–64. doi:10.6126/APMR.2011.16.1.04
48. Yang, K. P., Chiao, Y. C. ve Kuo, C. C. (2010). The relationship between R&D investment and firm profitability under a three-stage sigmoid curve model: Evidence from an emerging economy. IEEE Transactions on Engineering Management, 57(1), 103–117. doi:10.1109/TEM.2009.2023452